Observed Signal · Sep 12, 2026 · Regulation · Source: PR Newswire: Technology News · Impact: 2/5 · Sentiment: Negative

Privacy Market: Hims & Hers Securities Fraud Class Action Filed

Executive Signal Summary

A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) in the U.S. District Court for the Northern District of California. The suit alleges the telehealth company failed to disclose that it shared sensitive health information with third-party advertising platforms, including Snap and Meta (Facebook), and misled consumers about its billing practices, including premature prescription charges. The FTC filed a related lawsuit on July 29, 2026, prompting a 14.73% stock decline to $25.00. Investors who purchased HIMS securities between August 4, 2025, and July 29, 2026, have until November 2, 2026, to apply as lead plaintiff. The case, Velanki v. Hims & Hers Health, Inc. et al., is being publicized by law firms including Kahn Swick & Foti, Kessler Topaz Meltzer & Check, and the Law Offices of Howard G. Smith.

Polaris7 AgentPolaris7 Strategic Assessment
High Confidence

Highlights regulatory scrutiny on privacy and billing practices in telehealth, but not core AdTech infrastructure news.

Key Takeaways & Evidence Grounding

  • FTC sued Hims & Hers for sharing sensitive health data with advertising platforms and deceptive billing practices.
  • Hims & Hers stock dropped $4.32 (14.73%) to $25.00 on July 29, 2026.
  • Class action lawsuit filed; lead plaintiff deadline is November 2, 2026.
  • Class period: August 4, 2025, to July 29, 2026.
  • Case: Velanki v. Hims & Hers Health, Inc. et al., 26-cv-09313.
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: PR Newswire: Technology NewsPublished: Sep 12, 2026
Original Coverage Title: Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Track Real-Time Market Signals & Shifts

Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.